Nascent Biotech, Inc. Stock
Stocks
NBIO
US63108Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
13:38:59 2026-05-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.000300 USD | -.--% |
|
+50.00% | -50.00% |
| 24-08-14 | Nascent Biotech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024 | CI |
| 24-07-01 | Nascent Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Market Cap | 1.12M 1M 932K 848K 1.6M 106M 1.62M 11.2M 4.38M 55.52M 4.22M 4.13M 178M | P/E 2023 |
-2.38x | P/E 2024 | -13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 874K 780K 725K 659K 1.24M 82.77M 1.26M 8.71M 3.41M 43.18M 3.28M 3.21M 138M | EV / Sales 2023 |
-
| EV / Sales 2024 | - |
| Free-Float |
78.49% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | +50.00% | ||
| Current month | +50.00% | ||
| 1 month | +200.00% | ||
| 3 months | -50.00% | ||
| Current year | -50.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.08 |
| 1 year | 0 | | 0.13 |
| 3 years | 0 | | 0.28 |
| 5 years | 0 | | 0.45 |
| 10 years | 0 | | 0.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 58 | 2015-03-08 |
Lowell Holden
DFI | Director of Finance/CFO | 83 | 2014-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Lowell Holden
BRD | Director/Board Member | 83 | 2014-07-14 |
Sean Carrick
BRD | Director/Board Member | 58 | 2014-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/30/24 | Others | Chief Operating Officer | 50,000 | 0.0295% | ||
| 6/30/24 | Others | Chief Financial Officer | 96,000 | 0.0566% | ||
| 6/30/24 | Others | Chief Executive Officer | 192,000 | 0.1131% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +50.00% | -50.00% | -99.79% | 34.57K | |
| +0.21% | -7.67% | +61.07% | +71.32% | 68.92B | |
| +1.66% | -9.54% | +10.39% | +60.04% | 51.9B | |
| +3.14% | +4.61% | +15.36% | +44.42% | 48.73B | |
| +3.45% | +4.70% | +33.44% | +35.96% | 43.13B | |
| -2.20% | +0.61% | +281.88% | +532.76% | 41.48B | |
| +6.43% | +6.84% | +18.32% | +109.23% | 39.96B | |
| +1.28% | -0.76% | +12.67% | +45.10% | 30.6B | |
| -2.21% | -14.22% | +40.33% | -0.94% | 26.01B | |
| +1.74% | -2.02% | -13.55% | -12.92% | 22.27B | |
| Average | +1.35% | -3.51% | +40.99% | +78.52% | 37.3B | |
| Weighted average by Cap. | +1.58% | -3.49% | +54.95% | +105.30% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.8M -2.5M -2.32M -2.11M -3.98M -265M -4.05M -27.91M -10.92M -138M -10.51M -10.29M -443M | -2.09M -1.86M -1.73M -1.58M -2.96M -198M -3.02M -20.8M -8.14M -103M -7.83M -7.67M -330M |
| Net Debt | 217K 194K 180K 164K 309K 20.59M 314K 2.17M 848K 10.74M 816K 799K 34.38M | -250K -223K -207K -188K -354K -23.64M -361K -2.49M -973K -12.34M -937K -917K -39.47M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-14 | US$0.000200 | -.--% | 38,073 |
| 26-10-12 | US$0.000200 | -.--% | 12,000 |
- Stock Market
- Stocks
- NBIO Stock
Select your edition
All financial news and data tailored to specific country editions
